Browse Pet Safety Reports
17,908 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 17,908 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 17,908 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jun 26, 2024 | Horse | Arab | MSK | Colic | Outcome Unknown |
| Jun 26, 2024 | Horse | Mustang | MSK | INEFFECTIVE, GASTRIC ULCER(S); Inappropriate schedule of drug administration | Outcome Unknown |
| Jun 26, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 25, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 25, 2024 | Horse | Paint | MSK | Colic; Injection site tenderness | Recovered/Normal |
| Jun 25, 2024 | Horse | Percheron | MSK | Injection site swelling | Ongoing |
| Jun 24, 2024 | Horse | Horse (unknown) | MSK | Other abnormal test result NOS | Outcome Unknown |
| Jun 24, 2024 | Horse | Miniature | MSK | Sudden death | Died |
| Jun 24, 2024 | Horse | Appaloosa | MSK | Reluctant to move; Lethargy (see also Central nervous system depression in Ne... | Outcome Unknown |
| Jun 24, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 23, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy (bacteria) - NOS | Recovered/Normal |
| Jun 23, 2024 | Horse | Warmblood - Dutch | MSK | Conjunctivitis; Folliculitis; Lameness; Crust; Alopecia local; Neutropenia; L... | Ongoing |
| Jun 21, 2024 | Horse | Horse (unknown) | MSK | INEFFECTIVE, GASTRIC ULCER(S) | Outcome Unknown |
| Jun 21, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jun 20, 2024 | Horse | Paint | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 20, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 20, 2024 | Horse | Quarter Horse, Arab | MSK | Itching; Hypersensitivity reaction | Recovered/Normal |
| Jun 19, 2024 | Horse | Unknown, Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 19, 2024 | Horse | Pony (unspecified) | MSK | Inappetence | Recovered/Normal |
| Jun 18, 2024 | Horse | Thoroughbred | MSK | Injection site swelling; Intentional misuse | Ongoing |
| Jun 17, 2024 | Horse | Tennessee Walking Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 16, 2024 | Horse | Oldenburg | MSK | Injection site swelling; General illness | Recovered/Normal |
| Jun 14, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jun 14, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 14, 2024 | Horse | Paint | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 14, 2024 | Horse | Unknown | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 14, 2024 | Horse | Quarter Horse | MSK | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy; Incorrect dose admin... | Outcome Unknown |
| Jun 13, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 13, 2024 | Horse | Warmblood - Dutch | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 13, 2024 | Horse | Miniature | MSK | Death by euthanasia; Neurological signs NOS; Twitching; Stumbling gait; Nysta... | Euthanized |
| Jun 12, 2024 | Horse | Holsteiner | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 11, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jun 10, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 10, 2024 | Horse | Friesian, Horse (unknown) | MSK | Stiff gait; Gait abnormality; Lameness; Injection site swelling; Injection si... | Ongoing |
| Jun 9, 2024 | Horse | Morgan | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jun 6, 2024 | Horse | Horse (unknown) | MSK | Colic; Restlessness; Discomfort NOS; Injection site inflammation; Injection s... | Ongoing |
| Jun 6, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 6, 2024 | Horse | Quarter Horse | MSK | Injection site joint reaction | Ongoing |
| Jun 6, 2024 | Horse | Horse (other) | MSK | Injection site swelling; Other abnormal test result NOS; Reluctant to move | Recovered/Normal |
| Jun 4, 2024 | Horse | Clydesdale | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 4, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Jun 3, 2024 | Horse | Welsh Pony | MSK | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy | Outcome Unknown |
| Jun 3, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Ongoing |
| Jun 3, 2024 | Horse | Warmblood - Dutch | MSK | Injection site lump; Injection site swelling; Injection site thickening | Outcome Unknown |
| Jun 3, 2024 | Horse | Horse (unknown) | MSK | Colic; Death | Died |
| Jun 2, 2024 | Horse | Horse (unknown) | MSK | Lethargy (see also Central nervous system depression in Neurological) | Outcome Unknown |
| Jun 1, 2024 | Horse | Pura Raza Española (Andalus... | MSK | Depigmentation of nasal plane; Pigmentation disorder; Anorexia | Outcome Unknown |
| Jun 1, 2024 | Horse | Horse (unknown), Horse (unk... | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Jun 1, 2024 | Horse | Horse (unknown) | MSK | Allergy NOS | Outcome Unknown |
| Jun 1, 2024 | Horse | Trakehner | MSK | Behavioural disorder NOS; Abnormal vision (see also impaired vision) | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.